M. Arif, A. Basu, K. Wolf, J.K. Park, L. Pommerolle, M. Behee, R. Cinar
{"title":"为什么外周CB1R拮抗剂是肺纤维化的合理治疗策略?多组学方法建立翻译联系的证据","authors":"M. Arif, A. Basu, K. Wolf, J.K. Park, L. Pommerolle, M. Behee, R. Cinar","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2273","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":250436,"journal":{"name":"A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD","volume":"76 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Why Is Peripheral CB1R Antagonism a Rational Therapeutic Strategy for Pulmonary Fibrosis? Evidence From Multi-omics Approach for Establishing a Translational Link\",\"authors\":\"M. Arif, A. Basu, K. Wolf, J.K. Park, L. Pommerolle, M. Behee, R. Cinar\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2273\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":250436,\"journal\":{\"name\":\"A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD\",\"volume\":\"76 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2273\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Why Is Peripheral CB1R Antagonism a Rational Therapeutic Strategy for Pulmonary Fibrosis? Evidence From Multi-omics Approach for Establishing a Translational Link